Skip to content
10-Q

Quarterly Report

REGENXBIO Inc. RGNX

0001193125-25-268095

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 50.62M sh
Shares Diluted Q3 2025 · Sep 30, 2025 51.69M sh
Shares Diluted Q3 2025 · Sep 30, 2025 51.51M sh
Shares Diluted Q3 2025 · Sep 30, 2024 50.8M sh
Shares Diluted Q3 2025 · Sep 30, 2024 49.05M sh
Capex Q3 2025 · Sep 30, 2025 $1.91M
Capex Q3 2025 · Sep 30, 2024 $1.36M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$71.67M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$141.5M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $58.8M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $57.53M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $56.62M
Stockholders Equity Q3 2025 · Sep 30, 2025 $161.45M
Stockholders Equity Q3 2025 · Jun 30, 2025 $213.68M
Stockholders Equity Q3 2025 · Dec 31, 2024 $259.65M
Stockholders Equity Q3 2025 · Sep 30, 2024 $301.42M
Stockholders Equity Q3 2025 · Jun 30, 2024 $348.27M
Stockholders Equity Q3 2025 · Dec 31, 2023 $311.74M
Current Liabilities Q3 2025 · Sep 30, 2025 $124.57M
Current Liabilities Q3 2025 · Dec 31, 2024 $103.19M
Total Liabilities Q3 2025 · Sep 30, 2025 $363.75M
Total Liabilities Q3 2025 · Dec 31, 2024 $206.34M
Current Assets Q3 2025 · Sep 30, 2025 $331.97M
Current Assets Q3 2025 · Dec 31, 2024 $278M
Total Assets Q3 2025 · Sep 30, 2025 $525.2M
Total Assets Q3 2025 · Dec 31, 2024 $465.99M
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.20
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.46
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.17
Eps Diluted Q3 2025 · Sep 30, 2024 −$3.59
Eps Basic Q3 2025 · Sep 30, 2025 −$1.20
Eps Basic Q3 2025 · Sep 30, 2025 −$2.46
Eps Basic Q3 2025 · Sep 30, 2024 −$1.17
Eps Basic Q3 2025 · Sep 30, 2024 −$3.59
Sga Expense Q3 2025 · Sep 30, 2025 $20.25M
Sga Expense Q3 2025 · Sep 30, 2025 $60.48M
Sga Expense Q3 2025 · Sep 30, 2024 $19.42M
Sga Expense Q3 2025 · Sep 30, 2024 $56.57M
Rd Expense Q3 2025 · Sep 30, 2025 $56.1M
Rd Expense Q3 2025 · Sep 30, 2025 $168.69M
Rd Expense Q3 2025 · Sep 30, 2024 $54.43M
Rd Expense Q3 2025 · Sep 30, 2024 $158.14M
Net Income Q3 2025 · Sep 30, 2025 −$61.94M
Net Income Q3 2025 · Sep 30, 2025 −$126.73M
Net Income Q3 2025 · Sep 30, 2024 −$59.6M
Net Income Q3 2025 · Sep 30, 2024 −$175.92M
Operating Income Q3 2025 · Sep 30, 2025 −$52.41M
Operating Income Q3 2025 · Sep 30, 2025 −$103.56M
Operating Income Q3 2025 · Sep 30, 2024 −$62.08M
Operating Income Q3 2025 · Sep 30, 2024 −$181.98M
Revenue Q3 2025 · Sep 30, 2025 $29.73M
Revenue Q3 2025 · Sep 30, 2025 $140.1M
Revenue Q3 2025 · Sep 30, 2024 $24.2M
Revenue Q3 2025 · Sep 30, 2024 $62.11M